x

Science

Study: Sinopharm COVID-19 Vaccines Appear Safe, Effective

JAKARTA, Indonesia — Two vaccines made by China's Sinopharm appear safe and effective against COVID-19, according to a study published in a medical journal.

Scientists had been waiting for more details about the two vaccines, even though they already are being used in many countries, and one recently won the backing of the World Health Organization for emergency use.

The report, published online in the Journal of the American Medical Association, concluded the two vaccines are about 73% and 78% effective, as Sinopharm has previously claimed.

Researchers from Sinopharm and its local partners in the Middle East say the trial involved around 40,380 participants with the company's two vaccines — one developed by the Wuhan Institute of Biological Products and the other by the Beijing Institute of Biological Products — and a placebo. The trial was carried out in four countries — Bahrain, the United Arab Emirates, Egypt and Jordan. However, the study provided data for just Bahrain and the UAE. 

"There's nothing very surprising. It's consistent with what they have claimed previously, but it does not completely eliminate the doubts about Sinopharm," said Jin Dong-yan, a medical professor at the University of Hong Kong who was not involved with the study.

He raised doubts about how protective the vaccine was based on a recent surge of cases in the island nation of Seychelles, which had vaccinated a large majority of its population with the Sinopharm vaccine.

The study, performed mostly in younger men, had little information about the vaccine's effectiveness against severe disease. Some experts also expressed concern at the shortage of female participants, with nearly 85% being male.

"It's important to make sure you have tested it in enough women to be able to start seeing any possible safety concerns," said Ashley St. John, an associate professor at Duke-NUS Medical School in Singapore. 

A spokesperson for the company did not immediately respond to a request for comment.

The vaccines, both of which are made with inactivated viruses, have already been given to millions of people across the world.

The World Health Organization cleared the Beijing Institute of Biological Products' shot for emergency use in early May, making it the first Chinese vaccine to receive the certification. 

Chinese Foreign Minister Wang Yi said in April that China has provided vaccines to more than 100 countries, although it has not identified them. While China has six vaccines in use, the majority of its exports come from two companies: Sinopharm and Sinovac.

RELATED

CAPE CANAVERAL, Fla. (AP) — A moon lander that ended up on its side managed to beam back more pictures, with only hours remaining before it dies.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

NYC Officials Shutter Furniture Store Illegally Converted to House More than 40 Migrants

NEW YORK (AP) — A New York City furniture store that had been illegally converted into sleeping quarters for more than 40 migrants has been shut down by city officials.

The Philadelphia Orchestra's home is being renamed Marian Anderson Hall in honor of the pioneering Black American contralto, a rare case of an artist's name replacing a corporation.

DUBAI, United Arab Emirates (AP) — Two-time Wimbledon champion Andy Murray reiterated Monday that he is likely to retire from tennis before the season is over.

NEW YORK (AP) — Noel Fielding trades pastry for pistols in the new mouthful of a TV series “The Completely Made-Up Adventures of Dick Turpin,” a swashbuckling romp that's miles from the genteel tent of “The Great British Bake Off.

WASHINGTON (AP) — Hunter Biden appeared Wednesday on Capitol Hill for a closed-door deposition with lawmakers, a critical moment for Republicans as their impeachment inquiry into his father and their family's business affairs teeters on the brink of collapse.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.